BofA views the appointment of Tim Wentworth as Walgreens’ new CEO as “an incremental positive” given his extensive experience in the pharmacy supply chain. However, the firm lowered its price target on Walgreens Boots Alliance to $24 from $28 and keeps an Underperform rating on the shares, citing a lower multiple due to incremental concerns around cash flow and capital priorities without a permanent CFO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WBA: